Author:
Orlov Steven,Salari Farnaz,Kashat Lawrence,Freeman Jeremy L.,Vescan Allan,Witterick Ian J.,Walfish Paul G.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference28 articles.
1. S. Orlov, J.L. Freeman, P.G. Walfish, Radioiodine ablation in low-risk thyroid cancer. N Engl J Med 367(7), 672 (2012). doi: 10.1056/NEJMc1206712#SA1 . author reply 673-675
2. P.W. Rosario, A.F. Mineiro, B.S. Prates, L.C. Silva, M.R. Calsolari, Postoperative Stimulated Thyroglobulin = 1 ng/ml as a Criterion to Spare Low-Risk Patients with Papillary Thyroid Cancer from Radioiodine Ablation. Thyroid (2012). doi: 10.1089/thy.2012-0190
3. P.W. Rosario, A.C. Xavier, M.R. Calsolari, Value of postoperative thyroglobulin and ultrasonography for the indication of ablation and (1)(3)(1)I activity in patients with thyroid cancer and low risk of recurrence. Thyroid 21(1), 49–53 (2011). doi: 10.1089/thy.2010.0145
4. A.M. Sawka, J.D. Brierley, R.W. Tsang, L. Thabane, L.Rotstein, A. Gafni, S.Straus, D.P.Goldstein, An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol. Metab. Clin. North Am. 37(2), 457–480, x (2008). doi: 10.1016/j.ecl.2008.02.007
5. A.M. Sawka, K. Thephamongkhol, M. Brouwers, L. Thabane, G. Browman, H.C. Gerstein, Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 89(8), 3668–3676 (2004). doi: 10.1210/jc.2003-031167
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献